Abstract：
This study examined the proportion of Canadian adults who were on psychiatric medication prior to entering specialized outpatient care for an eating disorder, the types and combinations of medications taken, and predictors of being on a medication. A retrospective chart review of 223 adults with an eating disorder was conducted. A large proportion of the adults (61%) had been prescribed a psychiatric medication prior to entering specialized outpatient care. Of these adults, 74.6% were prescribed one medication and 24.3% were on a combination of two or more. Antidepressant and anti-anxiety medications were the most commonly prescribed (78%), while stimulant medications (2.1%), benzodiazepines (13.7%), and antipsychotics (10.7%) were also reported. Being at a higher weight status was a significant predictor of being on a psychiatric medication at intake assessment. Adults with comorbid depression were 2.68 times more likely to be on a psychiatric medication. Although the number of Canadian adults on psychiatric medication may well exceed the documented efficacy of these medications for eating disorders, psychopharmacological intervention could have been aimed at targeting comorbid conditions. Clinicians specializing in pharmacology and eating disorders may have an important role to provide psychoeducation to all providers.
摘要：
这项研究调查了在进入饮食失调的专门门诊治疗之前服用精神病药物的加拿大成年人的比例，服用药物的类型和组合，以及正在服药的预测因素。对223名患有进食障碍的成年人进行了回顾性图表审查。在进入专门的门诊治疗之前，很大一部分成年人（61％）已经开了精神科药物。在这些成年人中，74.6%的人被开了一种药物，24.3%的人被开了两种或两种以上的组合。抗抑郁和抗焦虑药物是最常用的处方（78％），而兴奋剂药物(2.1%)，苯二氮卓类药物（13.7%），和抗精神病药（10.7％）也报告。在摄入评估时，处于较高的体重状态是服用精神病药物的重要预测指标。患有共病抑郁症的成年人服用精神病药物的可能性是2.68倍。尽管加拿大成年人服用精神病药物的人数可能远远超过这些药物对饮食失调的疗效，精神药理学干预可能旨在针对合并症。专门从事药理学和饮食失调的临床医生可能在向所有提供者提供心理教育方面发挥重要作用。
